PD-1阻断-话题@MedSci

#PD-1阻断#

8篇内容 | 329人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1786910, encodeId=0d981e86910fd, content=<a href='/topic/show?id=05481391901' target=_blank style='color:#2F92EE;'>#PD-1阻断#</a>, objectTitle=Nat Med：经典霍奇金淋巴瘤患者PD-1阻断反应性的外周免疫特征, objectType=article, longId=209762, objectId=a266209e627b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a266209e627b, replyNumber=0, likeNumber=38, createdTime=2022-03-24, rootId=0, userName=wshxjq, userId=fd34186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a266209e627b, moduleTitle=Nat Med：经典霍奇金淋巴瘤患者PD-1阻断反应性的外周免疫特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a266209e627b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786909, encodeId=b3191e869095f, content=<a href='/topic/show?id=05481391901' target=_blank style='color:#2F92EE;'>#PD-1阻断#</a>, objectTitle=Nat Immun：PD-1阻断疗法有用吗？日本科学家提出一种新的疗效指标, objectType=article, longId=200668, objectId=3b24200668d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b24200668d8, replyNumber=0, likeNumber=41, createdTime=2020-11-07, rootId=0, userName=wshxjq, userId=fd34186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b24200668d8, moduleTitle=Nat Immun：PD-1阻断疗法有用吗？日本科学家提出一种新的疗效指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b24200668d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786908, encodeId=dd1a1e8690818, content=<a href='/topic/show?id=05481391901' target=_blank style='color:#2F92EE;'>#PD-1阻断#</a>, objectTitle=Sci Transl Med ：“双特异性抗体”助力PD-1阻断免疫疗法，抗肿瘤免疫更强更持久！, objectType=article, longId=199580, objectId=491e19958078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=491e19958078, replyNumber=0, likeNumber=45, createdTime=2021-05-13, rootId=0, userName=wshxjq, userId=fd34186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=491e19958078, moduleTitle=Sci Transl Med ：“双特异性抗体”助力PD-1阻断免疫疗法，抗肿瘤免疫更强更持久！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=491e19958078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786907, encodeId=5ea61e86907c6, content=<a href='/topic/show?id=05481391901' target=_blank style='color:#2F92EE;'>#PD-1阻断#</a>, objectTitle=Nat Med：透明细胞肾细胞肿瘤中体细胞变异和免疫浸润互作调控对PD-1阻断的响应, objectType=article, longId=195038, objectId=f5ec19503892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5ec19503892, replyNumber=0, likeNumber=33, createdTime=2020-10-11, rootId=0, userName=wshxjq, userId=fd34186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5ec19503892, moduleTitle=Nat Med：透明细胞肾细胞肿瘤中体细胞变异和免疫浸润互作调控对PD-1阻断的响应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5ec19503892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786906, encodeId=3be61e869064b, content=<a href='/topic/show?id=05481391901' target=_blank style='color:#2F92EE;'>#PD-1阻断#</a>, objectTitle=CLIN CANCER RES：Treg磷酸化STAT3增加以及抑制功能降低与转移性黑色素瘤患者PD-1阻断治疗获益有关, objectType=article, longId=156393, objectId=f98b15639322, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f98b15639322, replyNumber=0, likeNumber=41, createdTime=2019-10-08, rootId=0, userName=wshxjq, userId=fd34186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f98b15639322, moduleTitle=CLIN CANCER RES：Treg磷酸化STAT3增加以及抑制功能降低与转移性黑色素瘤患者PD-1阻断治疗获益有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f98b15639322)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786905, encodeId=19fb1e86905e9, content=<a href='/topic/show?id=05481391901' target=_blank style='color:#2F92EE;'>#PD-1阻断#</a>, objectTitle=CLIN CANCER RES：IDO1抑制剂增强放疗联合PD-1阻断对晚期胶质瘤的疗效, objectType=article, longId=140563, objectId=c0e914056343, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e914056343, replyNumber=0, likeNumber=39, createdTime=2019-01-06, rootId=0, userName=wshxjq, userId=fd34186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e914056343, moduleTitle=CLIN CANCER RES：IDO1抑制剂增强放疗联合PD-1阻断对晚期胶质瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0e914056343)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786903, encodeId=0c731e8690387, content=<a href='/topic/show?id=05481391901' target=_blank style='color:#2F92EE;'>#PD-1阻断#</a>, objectTitle=CLIN CANCER RES：PD-1阻断时机对联合免疫治疗疗效至关重要, objectType=article, longId=118085, objectId=19f611808541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19f611808541, replyNumber=0, likeNumber=44, createdTime=2018-07-12, rootId=0, userName=wshxjq, userId=fd34186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19f611808541, moduleTitle=CLIN CANCER RES：PD-1阻断时机对联合免疫治疗疗效至关重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19f611808541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786904, encodeId=dc371e8690469, content=<a href='/topic/show?id=05481391901' target=_blank style='color:#2F92EE;'>#PD-1阻断#</a>, objectTitle=CLIN CANCER RES：PD-1阻断和CD27活化可以协同增强CD8+T细胞抗肿瘤活性, objectType=article, longId=140166, objectId=017e140166f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=017e140166f6, replyNumber=0, likeNumber=33, createdTime=2018-08-04, rootId=0, userName=wshxjq, userId=fd34186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=017e140166f6, moduleTitle=CLIN CANCER RES：PD-1阻断和CD27活化可以协同增强CD8+T细胞抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=017e140166f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PD-1阻断

2020-05-29

wshxjq (审核中...)

前往app查看评论内容

#PD-1阻断#

Nat Med：经典霍奇金淋巴瘤患者PD-1阻断反应性的外周免疫特征

2022-03-24

wshxjq (审核中...)

前往app查看评论内容

#PD-1阻断#

Nat Immun：PD-1阻断疗法有用吗？日本科学家提出一种新的疗效指标

2020-11-07

wshxjq (审核中...)

前往app查看评论内容

#PD-1阻断#

Sci Transl Med ：“双特异性抗体”助力PD-1阻断免疫疗法，抗肿瘤免疫更强更持久！

2021-05-13

wshxjq (审核中...)

前往app查看评论内容

#PD-1阻断#

Nat Med：透明细胞肾细胞肿瘤中体细胞变异和免疫浸润互作调控对PD-1阻断的响应

2020-10-11

wshxjq (审核中...)

前往app查看评论内容

#PD-1阻断#

CLIN CANCER RES：Treg磷酸化STAT3增加以及抑制功能降低与转移性黑色素瘤患者PD-1阻断治疗获益有关

2019-10-08

wshxjq (审核中...)

前往app查看评论内容

#PD-1阻断#

CLIN CANCER RES：IDO1抑制剂增强放疗联合PD-1阻断对晚期胶质瘤的疗效

2019-01-06

wshxjq (审核中...)

前往app查看评论内容

#PD-1阻断#

CLIN CANCER RES：PD-1阻断时机对联合免疫治疗疗效至关重要

2018-07-12

wshxjq (审核中...)

前往app查看评论内容

#PD-1阻断#

CLIN CANCER RES：PD-1阻断和CD27活化可以协同增强CD8+T细胞抗肿瘤活性

2018-08-04

科室
- - 订阅+
  - 更多科室
工具
服务